Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Fagotti

Showing results (21-30 of 568) with videos related to

Pageof 57
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2020
Ovarian cancer treatment is evolving: more choices, more chancesClaudia Marchetti, Giovanni Scambia, Alessia Romito, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 12, 2025
Reply to "Methodological considerations on laparoscopic PIV in advanced ovarian cancer"Marco D'Indinosante, Denis Querleu, Diana Giannarelli, et al.
Annals of Translational Medicine|February 5, 2020
Secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: are we missing something?Claudia Marchetti, Andrea Rosati, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2024
New windows of surgical opportunity for gynecological cancers in the era of targeted therapiesInge Peters, Claudia Marchetti, Giovanni Scambia, et al.
Bulletin Du Cancer|March 2, 2023
Current and future trials about HIPEC in ovarian cancerValentina Ghirardi, Rita Trozzi, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2021
Response to: Should we or should we not? Risk reduction bilateral salpingectomy for BRCA mutation carriersGiacomo Corrado, Claudia Marchetti, Giovanni Scambia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2023
PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?Inge Peters, Claudia Marchetti, Anna Fagotti, et al.
Current Oncology Reports|August 15, 2022
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature ReviewDelphine Hudry, Stéphanie Bécourt, Giovanni Scambia, et al.
Current Treatment Options in Oncology|January 8, 2016
Current Recommendations for Minimally Invasive Surgical Staging in Ovarian CancerAnna Fagotti, Federica Perelli, Luigi Pedone, et al.
Annals of Surgical Oncology|March 6, 2024
ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking SurgeryValentina Ghirardi, Rita Trozzi, Giovanni Scambia, et al.
Pageof 57

Showing results (21-30 of 568) with videos related to

Sort By:
Pageof 57
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2020
Ovarian cancer treatment is evolving: more choices, more chancesClaudia Marchetti, Giovanni Scambia, Alessia Romito, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 12, 2025
Reply to "Methodological considerations on laparoscopic PIV in advanced ovarian cancer"Marco D'Indinosante, Denis Querleu, Diana Giannarelli, et al.
Annals of Translational Medicine|February 5, 2020
Secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: are we missing something?Claudia Marchetti, Andrea Rosati, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 4, 2024
New windows of surgical opportunity for gynecological cancers in the era of targeted therapiesInge Peters, Claudia Marchetti, Giovanni Scambia, et al.
Bulletin Du Cancer|March 2, 2023
Current and future trials about HIPEC in ovarian cancerValentina Ghirardi, Rita Trozzi, Giovanni Scambia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2021
Response to: Should we or should we not? Risk reduction bilateral salpingectomy for BRCA mutation carriersGiacomo Corrado, Claudia Marchetti, Giovanni Scambia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2023
PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?Inge Peters, Claudia Marchetti, Anna Fagotti, et al.
Current Oncology Reports|August 15, 2022
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature ReviewDelphine Hudry, Stéphanie Bécourt, Giovanni Scambia, et al.
Current Treatment Options in Oncology|January 8, 2016
Current Recommendations for Minimally Invasive Surgical Staging in Ovarian CancerAnna Fagotti, Federica Perelli, Luigi Pedone, et al.
Annals of Surgical Oncology|March 6, 2024
ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking SurgeryValentina Ghirardi, Rita Trozzi, Giovanni Scambia, et al.
Pageof 57